Fosamax, a drug used to fight osteoporosis, has been linked to jaw decay, also known as osteonecrosis. A Florida attorney filed a class action lawsuit against the drug maker Merck & Co. He believes Merck knew about the risks for years, while many doctors and patients are still not aware of the potential risks of ONJ for dental patients on bisphosphonates. Carey Hamilton, The Salt Lake Tribune 06/20/2006 Read Article: The Salt Lake Tribune Tuesday, June 20, 2006
Fosamax Risks Becoming More Apparent
Fosamax, a drug used to fight osteoporosis, has been linked to jaw decay, also known as osteonecrosis. A Florida attorney filed a class action lawsuit against the drug maker Merck & Co. He believes Merck knew about the risks for years, while many doctors and patients are still not aware of the potential risks of ONJ for dental patients on bisphosphonates. Carey Hamilton, The Salt Lake Tribune 06/20/2006 Read Article: The Salt Lake Tribune 
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment